Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation.
MacDonald KD, McKenzie KR, Zeitlin PL. Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation. Paediatr Drugs. 2007; 9(1):1-10.